Brain leptin and MC4R signaling critically regulate cardiometabolic function and protect organs from ischemic injury.

Cardiometabolic dysfunction, encompassing obesity, insulin resistance, glucose intolerance, and hyperlipidemia, represents a significant global health challenge. Current therapeutic approaches often fail to comprehensively address the intricate connections between metabolic and cardiovascular health. The central nervous system (CNS) plays a pivotal role in orchestrating these processes, with leptin receptors (LepRs) and melanocortin 4 receptors (MC4Rs) identified as key regulatory nodes. Deficiencies in these critical signaling pathways lead to severe metabolic abnormalities and sympathetic nervous system (SNS) dysfunction, impacting blood pressure (BP) regulation in ways not fully explained by obesity alone. Elucidating these central mechanisms offers a promising avenue for developing more integrated and effective therapeutic strategies.

This article presents a comprehensive review synthesizing existing literature on the multifaceted roles of central leptin and melanocortin 4 receptor (MC4R) signaling in cardiometabolic regulation. It meticulously examines the physiological importance of tonic activation of these pathways, the severe consequences of their deficiency, and their complex compensatory roles in the context of obesity. Furthermore, the review explores the compelling potential therapeutic implications of pharmacologically activating these brain receptors for the critical purpose of target organ protection against ischemic damage.

The review underscores that tonic activation of CNS LepRs and MC4Rs is indispensable for maintaining normal cardiometabolic function.

Deficiency in CNS LepR or MC4R signaling causes severe obesity, accompanied by multiple metabolic abnormalities including insulin resistance, glucose intolerance, and hyperlipidemia, which are only partially explained by obesity itself. These deficiencies also lead to significant SNS dysfunction and impaired BP regulation. In obesity, compensatory hyperleptinemia and activation of the CNS melanocortin system are crucial mechanisms that attenuate abnormalities of glucose and lipid metabolism. However, these compensatory responses may also paradoxically contribute to increased SNS activity and elevated BP. Importantly, pharmacological activation of brain LepRs and MC4Rs shows significant promise as a therapeutic approach for protecting target organs, such as the heart, kidneys, and brain, from ischemic injury by improving mitochondrial function and ATP production.